Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F6W7M
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,212
Award facts
- Contract value 100% obligated
- $28,212.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $28,212.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pen injections, with an ultimate completion date of January 13, 2026. This non-set-aside competitive award was issued on January 12, 2026, with performance occurring at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), serves as a critical pharmaceutical distributor for federal healthcare systems, particularly supporting military and veteran medical procurement needs.
This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), which functions as a comprehensive global pharmaceutical support vehicle. The IDC enables the contractor to supply an extensive portfolio of pharmaceutical products and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide, including serving the Defense Health Agency and U.S. Coast Guard. The award of Zepbound—a GLP-1 receptor agonist indicated for weight management—reflects the federal government's expanding pharmaceutical procurement needs within diabetes and metabolic health treatment categories.
Quick answers
Who was awarded contract SPE2DR26F6W7M?
SPE2DR26F6W7M was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F6W7M worth?
The government has obligated $28,212 on SPE2DR26F6W7M.
Is contract SPE2DR26F6W7M an order under another contract?
Yes. SPE2DR26F6W7M is a delivery order under SPE2DR25D3013, an indefinite delivery contract.
Was contract SPE2DR26F6W7M competed?
The extent of competition for SPE2DR26F6W7M was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award